Tore Duvold

Title: The Innovations of Tore Duvold

Introduction

Tore Duvold is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs for therapeutic applications. His work focuses on innovative solutions for treating proliferative diseases, including cancers.

Latest Patents

Duvold holds a patent for "Cyanoguanidine prodrugs," which includes pyridyl cyanoguanidine compounds. These compounds are characterized by a general formula that allows them to function as prodrugs in both human and veterinary therapy. The patent addresses the need for effective treatments for proliferative diseases, showcasing Duvold's commitment to advancing medical science.

Career Highlights

Tore Duvold is currently employed at Leo-Pharma A/S, a company renowned for its focus on dermatology and critical care. His role at the company allows him to leverage his expertise in drug development and contribute to innovative therapeutic solutions. Duvold's work is instrumental in enhancing the efficacy of treatments available for patients.

Collaborations

Duvold collaborates with Ernst T Binderup, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in pharmaceutical research.

Conclusion

Tore Duvold's contributions to the field of pharmaceuticals, particularly through his patent on cyanoguanidine prodrugs, highlight his role as an influential inventor. His work at Leo-Pharma A/S and collaborations with other professionals further emphasize his commitment to advancing medical therapies.